Hospira (HSP)

Add to Watchlists Create an Alert
35.08 -0.10  -0.28%   NYSE May 24, 8:00PM BATS Real time Currency in USD

Hospira SG&A Expense Quarterly:

186.10M for March 31, 2013
View Full Chart

Hospira SG&A Expense Quarterly Chart

    Hospira Historical SG&A Expense Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 186.10M
    Dec. 31, 2012 178.40M
    Sept. 30, 2012 155.20M
    June 30, 2012 169.90M
    March 31, 2012 184.20M
    Dec. 31, 2011 166.90M
    Sept. 30, 2011 149.60M
    June 30, 2011 155.60M
    March 31, 2011 165.20M
    Dec. 31, 2010 167.60M
    Sept. 30, 2010 158.90M
    June 30, 2010 169.90M
    March 31, 2010 178.60M
    Dec. 31, 2009 164.60M
    Sept. 30, 2009 162.40M
    June 30, 2009 146.30M
    March 31, 2009 145.50M
    Dec. 31, 2008 139.40M
    Sept. 30, 2008 145.60M
    June 30, 2008 152.70M
    March 31, 2008 Go Pro
       
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro

    About SG&A Expense

    SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

    The details of how SG&A expenses are calculated vary widely from company to company, so YCharts recommends looking at the annual report (10-k) an investor is interested in dissecting this number further.
    Learn More

    Get data for

    HSP SG&A Expense Quarterly Benchmarks

    Companies
    Durect Corporation 2.901M
    Cumberland Pharmaceuticals 6.250M
    Cubist Pharmaceuticals 50.25M

    HSP SG&A Expense Quarterly Rankings

    Overall 91st percentile
    687 of 8011
    Sector 89th percentile
    71 of 687 in Healthcare
    Industry 88th percentile
    8 of 69 in Drug Manufacturers - Specialty & Generic

    HSP SG&A Expense Quarterly Range, Past 5 Years

    Minimum 139.40M Dec 2008
    Maximum 186.10M Mar 2013
    Average 162.13M